Skip to main content
. 2023 Feb 15;12(4):e027674. doi: 10.1161/JAHA.122.027674

Table 3.

Univariable and Multivariable Cox Regression Models for New‐Onset AF After Propensity Score‐Matched Analysis

Variable Univariate model Multivariable model 1 Multivariable model 2 Multivariable model 3
Crude HR (95% CI) P value Adjusted HR (95% CI) P value Adjusted HR (95% CI) P value Adjusted HR (95% CI) P value
PVC count ≥1000 1.49 (1.15–1.91) 0.002 1.50 (1.17–1.94) 0.002 1.52 (1.18–1.97) 0.001 1.42 (1.09–1.84) 0.009
Age ≥60 3.26 (2.41–4.40) <0.001 3.39 (2.47–4.64) <0.001 3.49 (2.54–4.79) <0.001 3.71 (2.70–5.11) <0.001
Male 1.15 (0.91–1.46) 0.232 1.07 (0.85–1.36) 0.563 1.07 (0.85–1.36) 0.564 1.03 (0.81–1.32) 0.787
Diabetes 1.48 (1.16–1.90) 0.002 1.18 (0.91–1.52) 0.218 1.15 (0.89–1.49) 0.296 1.17 (0.90–1.51) 0.241
Hypertension 1.81 (1.41–2.33) <0.001 1.05 (0.80–1.38) 0.712 1.07 (0.82–1.42) 0.609 1.07 (0.82–1.41) 0.612
Heart failure 2.45 (1.88–3.18) <0.001 2.76 (2.11–3.59) <0.001 2.76 (2.12–3.61) <0.001 2.42 (1.83–3.20) <0.001
Coronary artery disease 1.37 (1.02–1.84) 0.035 1.16 (0.85–1.57) 0.354 1.16 (0.86–1.58) 0.331 1.17 (0.86–1.59) 0.318
Alcoholism 4.05 (1.51–10.89) 0.006 6.97 (2.56–18.94) <0.001 7.30 (2.68–19.85) <0.001
Hyperthyroidism 1.54 (0.82–2.90) 0.183 1.70 (0.88–3.28) 0.112 1.52 (0.78–2.96) 0.218
Use of antiarrhythmia drugs 2.26 (1.61–3.18) <0.001 2.02 (1.41–2.91) <0.001

AF indicates atrial fibrillation; HR, hazard ratio; and PVC, premature ventricular complex.